🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

What To-be-discard Biomaterials From ART Cycles Can Tell us About the Treatment Cycle Outcome?

Recruitingn/aAges 18 Years - anyAllChinese University of Hong Kong
NCT06021340 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Various to-be-discard material from IVF treatment cycle will be collect and examined, aiming to identify potential reasons of successful outcome or cycle failure.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients attending the Assisted Reproductive Technology (ART) Unit of the Chinese University of Hong Kong for ART treatment. * Participant able to give voluntary, written, informed consent to participate in the study. Exclusion Criteria: * Patient using donor gamete in IVF treatment * Patient refuses to join and failed to giving consent for any reasons
💊

What it tests

  • Not listed
📍

Where

1 site
The Chinese University of Hong Kong and Prince of Wales Hospital
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy